350P Safety and efficacy of durvalumab plus gemcitabine (gem)-based chemotherapy (chemo) regimens in participants (pts) with advanced biliary tract cancer (aBTC): Primary results from the phase IIIb TOURMALINE study

作者：D-Y. Oh, M. Ikeda, T. Macarulla Mercade, A.R. He, J.O. Park, M. Kitano, G. Giordano, K-P. Kim, T. Wirth, D. Tai, M. Bouattour, T. Pressiani, F. Dayyani, A. Lamarca Lete, U. Emeribe, S.M. Radke, P. Sun, B. Baur, A. Vogel · 发表于：Annals of Oncology · 年份：2026 · DOI：10.1016/j.annonc.2026.05.391 · 研究领域：Cholangiocarcinoma and Gallbladder Cancer Studies、Liver Diseases and Immunity、Gallbladder and Bile Duct Disorders